High frequencies of Granzyme B+ CD8+ cytotoxic T lymphocytes (CTLs) in the TME are necessary for effective antitumor immunity and are associated with improved prognoses and responses to immunotherapy in many cancer types (4, 5). The gene discussed is CD8A; the disease is cancer.